University of Minnesota. Driven to Discover.
In another new development, the NIH today announced the start of the first human trial of a live attenuated vaccine against Zika.
Trials of both an inactivated and a DNA vaccine showed good safety and immune response data.
The vaccine it has been developing with Walter Reed Army Institute of Research has been halted.
The patients, hospitalized at a speciality center, had a variety of complications and some unusual features.
In other Zika developments, a human rights group raised concerns about water, sanitation, and other public health concerns in Brazil, and India announced microcephaly screening for newborns.
A separate study found Zika virus in the saliva of 5 different mosquito species in Mexico.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.